Encysive, Glaxo Target Barr For Blood Clotting Generic
Encysive Pharmaceuticals Inc., GlaxoSmithKline and Mitsubishi Chemical Corp. have filed a patent infringement lawsuit to stop Barr Laboratories from producing a generic version of anti-blood clotting Argatroban injections....To view the full article, register now.
Already a subscriber? Click here to view full article